Frontmatter

Home Frontmatter

Article Publicly Available

Published/Copyright: June 10, 2016

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

"Frontmatter" Drug Metabolism and Personalized Therapy, vol. 31, no. 2, 2016, pp. i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

(2016). Frontmatter. Drug Metabolism and Personalized Therapy, 31(2), i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

(2016) Frontmatter. Drug Metabolism and Personalized Therapy, Vol. 31 (Issue 2), pp. i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

"Frontmatter" Drug Metabolism and Personalized Therapy 31, no. 2 (2016): i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

Frontmatter. Drug Metabolism and Personalized Therapy. 2016;31(2): i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

Copied to clipboard

Published Online: 2016-6-10

Published in Print: 2016-6-1

Articles in the same Issue

Frontmatter
In Memoriam Gérard Siest
Reviews
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
Mini Reviews
The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
Original Articles
Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function

Search journal Search the content of this journal

Frontmatter
In Memoriam Gérard Siest
Reviews
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
Mini Reviews
The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
Original Articles
Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function